{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dapagliflozin+tablet&page=2", "query": { "intervention": "Dapagliflozin tablet", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 92, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dapagliflozin+tablet&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dapagliflozin+tablet&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T23:21:30.173Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01068756", "title": "Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 14, "start_date": "2010-03", "completion_date": "2010-04", "has_results": false, "last_update_posted_date": "2016-10-17", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01068756" }, { "nct_id": "NCT01646320", "title": "Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Placebo matching with Dapagliflozin", "type": "DRUG" }, { "name": "Saxagliptin", "type": "DRUG" }, { "name": "Metformin immediate release (IR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 320, "start_date": "2012-09", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01646320" }, { "nct_id": "NCT07323524", "title": "Dapagliflozin in Active Lupus Nephritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lupus Nephritis (LN)" ], "interventions": [ { "name": "Dapagliflozin (10Mg Tab) along with standard medical therapy", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 33, "start_date": "2026-05-19", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07323524" }, { "nct_id": "NCT05435235", "title": "Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Kidney Injury", "Percutaneous Coronary Intervention" ], "interventions": [ { "name": "Dapagliflozin 10mg Tab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albert Einstein Healthcare Network", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2024-09-01", "completion_date": "2025-06", "has_results": false, "last_update_posted_date": "2024-07-31", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05435235" }, { "nct_id": "NCT01525238", "title": "PK Study of Dapagliflozin in Pediatric Subjects With T2DM", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 53, "start_date": "2012-07-01", "completion_date": "2014-09-01", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Los Angeles, California • Orlando, Florida + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525238" }, { "nct_id": "NCT05174052", "title": "Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus", "Atrial Fibrillation" ], "interventions": [ { "name": "Dapagliflozin 10Mg Tab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 28, "start_date": "2022-06-01", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT05174052" }, { "nct_id": "NCT05516498", "title": "Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Liver Cirrhosis" ], "interventions": [ { "name": "Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet)", "type": "DRUG" }, { "name": "Part A: zibotentan (dose B) + dapagliflozin", "type": "DRUG" }, { "name": "Part B: Placebo (matching zibotentan capsule & matching dapagliflozin tablet)", "type": "DRUG" }, { "name": "Part B: placebo (matching zibotentan capsule) + dapagliflozin", "type": "DRUG" }, { "name": "Part B: zibotentan (dose A) + dapagliflozin", "type": "DRUG" }, { "name": "Part B: zibotentan (dose B) + dapagliflozin", "type": "DRUG" }, { "name": "Part B: zibotentan (dose C) + dapagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 205, "start_date": "2022-10-31", "completion_date": "2025-07-17", "has_results": true, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Pasadena, California • San Francisco, California + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pasadena", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "West Hollywood", "state": "California" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05516498" }, { "nct_id": "NCT00643851", "title": "An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Metformin XR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "77 Years", "sex": "ALL", "summary": "18 Years to 77 Years" }, "enrollment_count": 994, "start_date": "2008-06", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2023-01-30", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 44, "location_summary": "Birmingham, Alabama • Haleyville, Alabama • Tempe, Arizona + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Haleyville", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643851" }, { "nct_id": "NCT06762964", "title": "CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fontan Circulation", "Single Ventricle Heart Disease", "HFpEF - Heart Failure With Preserved Ejection Fraction" ], "interventions": [ { "name": "Dapagliflozin tablet", "type": "DRUG" }, { "name": "Placebo Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2025-05-16", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06762964" }, { "nct_id": "NCT03036150", "title": "A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 4304, "start_date": "2017-02-02", "completion_date": "2020-06-12", "has_results": true, "last_update_posted_date": "2021-07-07", "last_synced_at": "2026-10-01T23:21:30.173Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Hawaiian Gardens, California • Lomita, California + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hawaiian Gardens", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03036150" } ] }